We are live on
!
Find out more
CS
Credit Suisse Portfolio holdings
AUM
$104B
1-Year Est. Return
34.76%
This Fund
S&P 500
This Quarter
Est. Return
+0.25%
1 Year Est. Return
+34.76%
3 Year Est. Return
+49.35%
5 Year Est. Return
+181.01%
10 Year Est. Return
+395.52%
AUM
$119B
AUM Growth
+$5.64B
(+5%)
Cap. Flow
+$6.41B
Cap. Flow
% of AUM
5.41%
Top 10 Holdings %
Top 10 Hldgs %
16.36%
Holding
4,406
New
331
Increased
2,055
Reduced
1,449
Closed
309
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$1.02B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$944M |
| 3 |
AT&T
T
|
+$753M |
| 4 |
Vanguard Extended Market ETF
VXF
|
+$553M |
| 5 |
Linde
LIN
|
+$379M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
APC
Anadarko Petroleum
APC
|
+$331M |
| 2 |
FDC
First Data Corporation
FDC
|
+$331M |
| 3 |
GWR
Genesee & Wyoming Inc.
GWR
|
+$312M |
| 4 |
Blackstone
BX
|
+$277M |
| 5 |
FirstEnergy
FE
|
+$261M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 11.59% |
| 2 | Technology | 10.75% |
| 3 | Financials | 9.31% |
| 4 | Consumer Discretionary | 6.45% |
| 5 | Communication Services | 5.5% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SRDX
3401
DELISTED
Surmodics
SRDX
| $433K | ﹤0.01% |
9,472
-295
| -3% | -$12.9K |
|
|
ACH
3402
DELISTED
Alum Corp of China Ltd
ACH
| $433K | ﹤0.01% |
55,431
+2,327
| +4% | +$18.5K |
|
3403
Full House Resorts
FLL
$80.1M
| $432K | ﹤0.01% |
200,000
| – | – |
|
3404
Adtran
ADTN
$689M
| $431K | ﹤0.01% |
38,003
+3,472
| +10% | +$41.3K |
|
3405
TG Therapeutics
TGTX
$7.96B
| $430K | ﹤0.01% |
76,564
+27,059
| +55% | +$189K |
|
3406
Great Southern Bancorp
GSBC
$874M
| $427K | ﹤0.01% |
7,499
+1,003
| +15% | +$57.9K |
|
3407
Plug Power
PLUG
$2.87B
| $427K | ﹤0.01% |
162,331
-23,115
| -12% | -$53.6K |
|
3408
Gorman-Rupp
GRC
$2.14B
| $426K | ﹤0.01% |
12,242
+2,075
| +20% | +$65.9K |
|
3409
A10 Networks
ATEN
$2.13B
| $425K | ﹤0.01% |
61,264
+8,944
| +17% | +$64.3K |
|
3410
Central Garden & Pet Co
CENT
$2.69B
| $425K | ﹤0.01% |
18,208
-97,573
| -84% | -$2.11M |
|
|
HHR
3411
DELISTED
HeadHunter Group PLC American Depositary Shares
HHR
| $425K | ﹤0.01% |
+22,054
| New | +$408K |
|
3412
Omega Flex
OFLX
$297M
| $423K | ﹤0.01% |
4,140
-205
| -5% | -$17K |
|
|
SHOE
3413
Shoe Station Group
SHOE
$413M
| $423K | ﹤0.01% |
26,156
-556
| -2% | -$7.73K |
|
3414
BrightView Holdings
BV
$1.22B
| $422K | ﹤0.01% |
24,631
+10,564
| +75% | +$195K |
|
3415
Cerus
CERS
$433M
| $420K | ﹤0.01% |
81,541
+8,482
| +12% | +$45.5K |
|
3416
Impinj
PI
$4.62B
| $420K | ﹤0.01% |
+13,632
| New | +$476K |
|
|
OEFA
3417
ALPS O'Shares International Developed Quality Dividend ETF
OEFA
$36.5M
| $419K | ﹤0.01% |
17,512
+8,176
| +88% | +$193K |
|
3418
Zymeworks
ZYME
$1.61B
| $419K | ﹤0.01% |
+16,898
| New | +$423K |
|
|
HMHC
3419
DELISTED
Houghton Mifflin Harcourt Company
HMHC
| $419K | ﹤0.01% |
78,526
+1,484
| +2% | +$8.38K |
|
3420
Harmonic Inc
HLIT
$1.25B
| $418K | ﹤0.01% |
63,680
+3,364
| +6% | +$23.3K |
|
3421
Vanguard FTSE Developed Markets ETF
VEA
$229B
| $417K | ﹤0.01% |
10,147
-9,122
| -47% | -$373K |
|
3422
Agilysys
AGYS
$2.97B
| $415K | ﹤0.01% |
16,207
+4,499
| +38% | +$114K |
|
3423
Tactile Systems Technology
TCMD
$635M
| $415K | ﹤0.01% |
9,798
-1,755
| -15% | -$90.7K |
|
|
CPLG
3424
DELISTED
CorePoint Lodging Inc. Common Stock
CPLG
| $415K | ﹤0.01% |
41,024
+3,070
| +8% | +$33.2K |
|
3425
RE/MAX Holdings
RMAX
$193M
| $414K | ﹤0.01% |
12,862
-234
| -2% | -$6.64K |
|
Similar funds
CSIA
CAN
VAM
CA
MNG
DPAM
ICG
CW
Credit Suisse's Q3 2019 Portfolio in Review
As of Q3 2019, Credit Suisse held 4,406 positions worth $119B, up 5% from $113B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Credit Suisse deployed $6.41B of net new capital in Q3 2019, opening 331 new positions and adding to 2,055 existing holdings. Its largest new stake was GW Pharmaceuticals Plc American Depositary Shares: 200,027 shares worth $23M.
By sector, the portfolio is most concentrated in Healthcare at 12% of assets, up from 11% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Genesee & Wyoming Inc., an estimated $312M trimmed.
- Credit Suisse's largest Q3 2019 buy was GW Pharmaceuticals Plc American Depositary Shares: 200,027 shares worth $23M.
- Credit Suisse added most to Allergan plc in Q3 2019, an estimated $1.02B increase.
- Credit Suisse's biggest Q3 2019 reduction was Genesee & Wyoming Inc., cutting an estimated $312M.
- Credit Suisse fully exited Anadarko Petroleum in Q3 2019, selling an estimated $331M.
- Credit Suisse's ten largest holdings make up 16% of its $119B portfolio in Q3 2019.
- Credit Suisse opened 331 new positions and closed 309 in Q3 2019.
- Credit Suisse's portfolio value rose 5% quarter-over-quarter to $119B.
Based on Credit Suisse's 13F filing for Q3 2019, filed 12 Nov 2019.